1. Volume 152, Issue 3, Pages 540-547 (March 2019)
Brachytherapy: A critical component of primary radiation therapy for cervical cancer 
Christine H. Holschneider, Daniel G. Petereit, Christina Chu, I-Chow Hsu, Yevgeniya J. Ioffe, Ann H. Klopp, Bhavana Pothuri, Lee-may Chen, Catheryn Yashar 
Gynecologic Oncology 
Volume 152, Issue 3, Pages (March 2019)
DOI: /j.ygyno
Copyright © 2018 Elsevier Inc., American Brachytherapy Society Terms and Conditions

2. Fig. 1
Adjusted overall survival by boost modality (brachytherapy vs. IMRT/SBRT) as corrected for age, Charlson/Deyo comorbidity score, stage, and chemotherapy utilization. (Reprinted from Gill BS, Lin JF, Krivak TC, et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. Int J Radiat Oncol Biol Phys 2014; 90:1083–90; with permission from Elsevier.)
Gynecologic Oncology  , DOI: ( /j.ygyno )
Copyright © 2018 Elsevier Inc., American Brachytherapy Society Terms and Conditions